1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Dec 2021
Admin
News Article

Durect And Innocoll Announce A $136 Million Us Licensing Agreement For Posimir

Durect To Receive Near-Term Upfront Cash Payments Totaling $6 Million, Potential Additional Milestone Payments Of Up To $130 Million And Tiered Low To Mid Double-Digit Royalties Based On U.S. Sales- Innocoll Granted Exclusive Development And Commercialization Rights To Posimir In The United States- Durect To Discuss Agreement On Conference Call Et Durect To Receive Near-Term Upfront Cash Payments Totaling $6 Million, Potential Additional Milestone Payments Of Up To $130 Million And Tiered Low To Mid Double-Digit Royalties Based On Us Sales- Innocoll Granted Exclusive Development And Commercialization Rights To Posimir In The United States- Durect To Discuss Agreement On Conference Call Innocoll Biotherapeutics Plc Is A Global Specialty Pharmaceutical Company Headquartered In Athlone, Ireland. Innocoll Biotherapeutics Plc And Its Subsidiaries Innocoll Holdings Limited And Innocoll Pharmaceuticals Limited, Are Focused On The Development And Commercialization Of Pharmaceutical Technologies To Meet Some Of Today'S Most Important Healthcare Challenges. Innocoll Biotherapeutics Plc Is A Portfolio Business Of Gurnet Point Capital. Www.Innocoll.ComAbout PosimirPosimir

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!